4th Quarter - Termination

ML STRATEGIES, LLC for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$50,000
Expenses
—
Terminated
Nov 30, 2014

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.4857, Ensuring Equal Access to Treatments Act of 2014; H.R. 3230, Veterans Access, Accountability Act of 2014, provisions related to prescription drug services.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobby Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US lobbies and listed above.

LobbyistCovered position, as disclosed
ABBY MATOUSEK —
JEREMY RABINOVITZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3230 (113th), H.R. 4857 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.